Bladder Cancer Trial, Recruiting NCT05715684 Sponsor: Dana-Farber Cancer Institute Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT05715684
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 85 years of age who are scheduled for a full bladder removal surgery (cystectomy), performed either as open surgery or using a robotic approach.
  • People whose surgery will include a specific type of urinary diversion — either an ileal conduit (where urine drains into an external bag) or an ileal neobladder (where a new bladder is created from part of the intestine).
  • People with a physical health status rating of class 1 to 4 on the anaesthesiologist's standard fitness scale (confirm with trial site).
  • People who are able to understand the study procedures and have agreed to take part by signing a consent form.

Who may not be able to join:

  • People scheduled for a partial bladder removal only.
  • People who have previously had their entire colon or stomach removed, or have had gastric bypass surgery, or who currently have a permanent colostomy or ileostomy.
  • People who have taken more than three doses of opioid pain medicines (by mouth or injection) in the seven days before surgery.
  • People whose cancer has spread to other parts of the body (metastatic cancer).
  • People currently receiving treatment for another type of cancer at the same time.
  • People who have received chemotherapy for bladder cancer within one month before the scheduled surgery (prior chemotherapy given before surgery to shrink a tumour is generally allowed — confirm with trial site).
  • People who are pregnant, breastfeeding, or who are of childbearing potential and are not using an accepted form of birth control (confirm with trial site for the full list of accepted methods).
  • People who have taken part in another clinical trial for a drug or medical device within 30 days of surgery, or who plan to join another such study during this trial.
  • People who have significant abnormal blood or lab test results at the screening stage that would have led to the cancellation of surgery.
  • People who are currently using illegal drugs or misusing alcohol.
  • People with a history of past surgeries, illnesses, or behavioural or mental health conditions (such as depression or psychosis) that, in the opinion of the trial doctor, could affect the results or pose additional risk.
  • People with severe dementia that affects their ability to carry out daily activities.
  • People with severe liver disease, classified as Child-Pugh Class C (people with milder liver disease in Class A or B may still be considered).
  • People with a history of heart failure or current heart failure.
  • People with very advanced kidney disease, where the kidney filtration rate is below 15 (end-stage renal disease).
  • People with a complete blockage of the digestive tract.
  • People who have a feeding tube (such as a gastrostomy or jejunostomy tube) or who require tube feeding.
  • People who do not speak English.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617-732-6384

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
27 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total days hospitalized within 30-days of surgery; Length of stay; Number and type of minor and major complications; Discharge disposition; Readmissions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov